US Patent

US11583510 — Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Method of Use · Assigned to Flamel Ireland Ltd · Expires 2042-02-07 · 16y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods of administering a once-nightly dosage of gamma-hydroxybutyrate after a high-fat meal.

USPTO Abstract

Provided herein are methods of administering a once-nightly dosage of gamma-hydroxybutyrate after a high-fat meal.

Drugs covered by this patent

sodium-oxybate (SODIUM OXYBATE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3578`	—	sodium-oxybate
`U-3578`	—	sodium-oxybate
`U-3578`	—	sodium-oxybate
`U-3578`	—	sodium-oxybate

Patent Metadata

Patent number: US11583510
Jurisdiction: US
Classification: Method of Use
Expires: 2042-02-07
Drug substance claim: No
Drug product claim: No
Assignee: Flamel Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.